© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Greenland Mines Ltd. (GRML) stock declined over -17.54%, trading at $3.15 on NASDAQ, down from the previous close of $3.82. The stock opened at $3.82, fluctuating between $3.14 and $3.95 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 3.82 | 3.95 | 3.13 | 3.15 | 866.16K |
| Sep 10, 2026 | 4.08 | 4.15 | 3.82 | 3.82 | 349.47K |
| Sep 09, 2026 | 4.40 | 4.40 | 4.15 | 4.19 | 343.89K |
| Sep 08, 2026 | 4.73 | 4.78 | 4.33 | 4.35 | 411.76K |
| Sep 04, 2026 | 4.44 | 4.98 | 4.39 | 4.76 | 785.18K |
| Sep 03, 2026 | 4.94 | 5.02 | 4.45 | 4.48 | 648.69K |
| Sep 02, 2026 | 4.90 | 5.09 | 4.60 | 4.87 | 1.05M |
| Sep 01, 2026 | 4.79 | 4.85 | 4.55 | 4.65 | 407.34K |
| Aug 31, 2026 | 4.77 | 5.25 | 4.73 | 4.85 | 599.59K |
| Aug 28, 2026 | 5.25 | 5.45 | 4.88 | 4.88 | 507.47K |
| Aug 27, 2026 | 5.07 | 5.48 | 4.37 | 5.26 | 1.57M |
| Aug 26, 2026 | 5.40 | 5.65 | 5.00 | 5.04 | 2.75M |
| Aug 25, 2026 | 10.30 | 11.66 | 8.76 | 9.71 | 2.6M |
| Aug 24, 2026 | 9.43 | 9.56 | 8.30 | 8.55 | 237.1K |
| Aug 21, 2026 | 8.30 | 12.70 | 8.23 | 10.14 | 1.56M |
| Aug 20, 2026 | 8.95 | 9.75 | 7.90 | 8.30 | 219.87K |
| Aug 19, 2026 | 9.45 | 10.41 | 9.45 | 10.33 | 51.62K |
| Aug 18, 2026 | 9.90 | 9.90 | 9.40 | 9.40 | 23.91K |
| Aug 17, 2026 | 10.25 | 10.54 | 9.71 | 9.96 | 95.71K |
| Aug 14, 2026 | 10.00 | 10.64 | 10.00 | 10.17 | 40.92K |
Greenland Mines Ltd operates across two segments: natural resources and cell and gene therapy. Its resources arm is focused on exploring for palladium, gold, and platinum, centered on the exploration and development of the Skaergaard project in Southeast Greenland. On the therapeutics side, the company is developing KLTO-202, a gene therapy targeting the treatment and prevention of amyotrophic lateral sclerosis (ALS), and KLTO-101, aimed at treating or preventing Alzheimer's disease, alongside therapies for Parkinson's and other age-related conditions. Previously known as Klotho Neurosciences, Inc., the company adopted its current name in March 2026. It is headquartered in Charlotte, North Carolina.
| Employees | 5 |
| Beta | 2.48 |
| Sales or Revenue | N/A |
| 5Y Sales Change% | N/A |
| Fiscal Year Ends | N/A |
| Sector | Basic Materials |
| Industry | Other Precious Metals |